ScholarX: Browsing ScholarWorks

Browsing by Hayashi, HidetoshiAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Sort by: In order: Results/Page Authors/Record:

Showing results 1 to 8 of 8

SCIESCOPUS

Amivantamab plus Lazertinib in Previously Untreated <i>EGFR</i>-Mutated Advanced NSCLC

Cho, Byoung C.; Lu, Shun; Felip, Enriqueta; Spira, Alexander I.; Girard, Nicolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yurii; Danchaivijitr, Pongwut; Liu, Baogang, et al.

ArticleIssue Date2024CitationNEW ENGLAND JOURNAL OF MEDICINEPublisherMASSACHUSETTS MEDICAL SOC

SCIESCOPUS

Amivantamab Plus Lazertinib vs Osimertinib as First-line Treatment in Patients With EGFR-mutated, Advanced Nonsmall Cell Lung Cancer (NSCLC): Primary Results From MARIPOSA, a Phase 3, Global, Randomized, Controlled Trial (Previously presented at ESMO Congress 2023, FPN:LBA14, Byoung Chul Cho et al. - Reused with permission.)

Schuler, Martin; Cho, Byoung Chul; Felip, Enriqueta; Spira, Alexander; Girard, Niolas; Lee, Jong-Seok; Lee, Se-Hoon; Ostapenko, Yuriy; Danchaivijitr, Pongwut; Liu, Baogang, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 260 - 261PublisherKARGER

SCIESCOPUS

Datopotamab deruxtecan (Dato-DXd) vs docetaxel in previously treated advanced/metastatic (adv/met) non-small cell lung cancer (NSCLC): Results of the randomized phase III study TROPION-Lung01

Atmaca, Akin; Ahn, Myung-Ju; Lisberg, Aaron; Paz-Ares, Luis; Cornelissen, Robin; Girard, Nicolas; Pons-Tostivint, Elvire; Baz, David Vicente; Sugawara, Shunichi; Cobo, Manuel Angel, et al.

ArticleIssue Date2024CitationONCOLOGY RESEARCH AND TREATMENT, v.47, pp 245 - 245PublisherKARGER

SCIESCOPUS

Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study

Ahn, Myung-Ju; Tanaka, Kentaro; Paz-Ares, Luis; Cornelissen, Robin; Girard, Nicolas; Pons-Tostivint, Elvire; Vicente Baz, David; Sugawara, Shunichi; Cobo, Manuel; Pérol, Maurice, et al.

ArticleIssue Date2025CitationJournal of Clinical Oncology, v.43, no.3PublisherLippincott Williams and Wilkins

SCIESCOPUS

HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy open access

Yu, Helena A.; Goto, Yasushi; Hayashi, Hidetoshi; Felip, Enriqueta; Chih-Hsin Yang, James; Reck, Martin; Yoh, Kiyotaka; Lee, Se-Hoon; Paz-Ares, Luis; Besse, Benjamin, et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.35, pp 5363 - 5375PublisherLippincott Williams and Wilkins

SCIESCOPUS

Trastuzumab deruxtecan (T-DXd) in patients with <i>HER2</i>-mutant metastatic non-small cell lung cancer (mNSCLC): Final analysis results of DESTINY-Lung02.

Janne, Pasi A.; Goto, Yasushi; Kubo, Toshio; Ninomiya, Kiichiro; Kim, Sang-We; Planchard, David; Ahn, Myung-Ju; Smit, Egbert F.; De langen, Adrianus Johannes; Perol, Maurice, et al.

ArticleIssue Date2024CitationJOURNAL OF CLINICAL ONCOLOGY, v.42, no.16PublisherLIPPINCOTT WILLIAMS & WILKINS

SCIESCOPUS

Trastuzumab Deruxtecan in Patients with HER2-Mutant Metastatic Non-Small-Cell Lung Cancer: Primary Results from the Randomized, Phase II DESTINY-Lung02 Trial open access

Goto, Koichi; Goto, Yasushi; Kubo, Toshio; Ninomiya, Kiichiro; Kim, Sang-We; Planchard, David; Ahn, Myung-Ju; Smit, Egbert F.; de Langen, Adrianus Johannes; Pérol, Maurice, et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.31, pp 4852 - 4863PublisherLippincott Williams and Wilkins

SCIESCOPUS

Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study open access

Nakamura, Yoshiaki; Mizuno, Nobumasa; Sunakawa, Yu; Canon, Jean-Luc; Galsky, Matthew D.; Hamilton, Erika; Hayashi, Hidetoshi; Jerusalem, Guy; Kim, Seung Tae; Lee, Keun-Wook, et al.

ArticleIssue Date2023CitationJournal of Clinical Oncology, v.41, no.36, pp 5569 - 5578PublisherLippincott Williams and Wilkins

STATISTICS: Total View:; Daily View:

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREA samsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Browsing by Hayashi, HidetoshiAuthor

BROWSE